Inogen vs STERIS: revenue, profit, margins and growth compared
Inogen brought in $348.7M of revenue in fiscal 2025, STERIS $5.9B in fiscal 2026. Revenue changed by +3.9% at Inogen and +8.7% at STERIS on the year before, so STERIS grew faster. Inogen kept -6.5% of its revenue as net profit, STERIS 13.2%. Free cash flow was -$13.7M at Inogen and $972.4M at STERIS.
Fiscal years as each company reports them; the two may end in different months.
Questions about Inogen and STERIS
Which is bigger by revenue, Inogen or STERIS?
STERIS is bigger by revenue: $5.9B in fiscal 2026, against $348.7M for Inogen in fiscal 2025.
Which keeps more of its revenue as profit, Inogen or STERIS?
Inogen had a net margin of -6.5% in fiscal 2025; STERIS had 13.2% in fiscal 2026.
Which grew revenue faster, Inogen or STERIS?
In their latest fiscal years revenue changed by +3.9% at Inogen and +8.7% at STERIS.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.